SynCAR-M

N/A

Report date: 2022/01/10 16:27:59

Base Information

Drug NameSynCAR-M
Drug Alias NameSynCAR-M
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Syngentech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Syngentech Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A